BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 10.6% of their position (5K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $611.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 7/8/2026ACC: 0001197350-26-000008
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
-5K
Net shares
Net seller
$611.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
5K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−3.12K
Price / share
$121.67
Trade value
$380.10K
% of position
6.6%
7/6/2026
47.18K→44.06K
Common Stock
Direct
Shares
−1.05K
Price / share
$122.43
Trade value
$128.31K
% of position
2.4%
7/6/2026
44.06K→43.01K
Common Stock
Direct
Shares
−528.00
Price / share
$123.84
Trade value
$65.39K
% of position
1.2%
7/6/2026
43.01K→42.48K
Common Stock
Direct
Shares
−300.00
Price / share
$124.94
Trade value
$37.48K
% of position
0.7%
7/6/2026
42.48K→42.18K
Total
Net shares
−5K
Net value
-$611.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | S · Sale | −3.12K | $121.67 | $380.10K | 6.6% | 47.18K | 44.06K |
| Common Stock Direct | 7/6/2026 | S · Sale | −1.05K | $122.43 | $128.31K | 2.4% | 44.06K | 43.01K |
| Common Stock Direct | 7/6/2026 | S · Sale | −528.00 | $123.84 | $65.39K | 1.2% | 43.01K | 42.48K |
| Common Stock Direct | 7/6/2026 | S · Sale | −300.00 | $124.94 | $37.48K | 0.7% | 42.48K | 42.18K |
| Total | −5K | -$611.27K | ||||||
Derivative Transactions0
No derivative transactions reported